Screening for circulating tumor DNA from peripheral blood is low invasive and provides fast results, and we suggest screening for HPVP HNSCC using a panel, including RBM24, INHBA, SYCP2, TAFL7, and ZFR2. This evidence concerns the gene INHBA and neoplasm.